Role of JTT-501, a new insulin sensitiser, in restoring impaired GLUT4 translocation in adipocytes of rats fed a high fat diet

Diabetologia

Volumn 41, Issue 4, 1998, Pages 400-409

  Terasaki, J ^a   Anai, M ^a   Funaki, M ^b   Shibata, T ^c   Inukai, K ^a   Ogihara, T ^b   Ishihara, H ^b   Katagiri, H ^b   Onishi, Y ^b   Sakoda, H ^b   Fukushima, Y ^b   Yazaki, Y ^b   Kikuchi, M ^a   Oka, Y ^d   Asano, T ^b  

^a INSTITUTE FOR ADULT DISEASES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPAN TOBACCO INC   (Japan)

^d YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

Adipocyte; GLUT4; High fat diet; Insulin sensitiser; Isoxazolidinedione; JTT 501; Phosphatidylinositol 3 kinase

Indexed keywords

ADIPOCYTE; ARTICLE; DIETARY INTAKE; ENZYME ACTIVITY; FAT INTAKE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; GLUCOSE TRANSPORT SYSTEM; IMMUNOPRECIPITATION; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN PHOSPHORYLATION;

ADIPOCYTES; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CELL MEMBRANE; CELLS, CULTURED; DIETARY FATS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, INTRAVENOUS; INSULIN; ISOXAZOLES; KINETICS; MALE; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 6844222829     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050922     Document Type: Article

References (65)

1. Olefsky JM, Kolterman OG, Scarlett JA (1982) Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am J Physiol 243: E15-30
2. Dohm GL, Tapscott EB, Pories WJ et al. (1988) An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic sujects. J Clin Invest 82: 486-494
3. Taylor R (1989) Aetiology of non-insulin dependent diabetes. Br Med Bull 45: 73-91
4. DeFronzo RA, Ferrannini E (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194
5. Saltiel AR, Olefsky JM (1996) Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45: 1661-1669
6. Sandouk T, Reda D, Hofmann C (1993) Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells. Am J Physiol 264: C1600-1608
7. Szalkowski D, White-Carrington S, Berger J, Zhang B (1995) Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells. Endocrinology 136: 1474-1481
8. Cushman SW, Wardzala LJ (1980) Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane. J Biol Chem 255: 4758-4762
9. Suzuki K, Kono T (1980) Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site. Proc Natl Acad Sci USA 77: 2542-2545
10. Ciaraldi TP, Kolterman OG, Scarlett JA, Kao M, Olefsky JM (1982) Role of glucose transport in the postreceptor defect of non-insulin dependent diabetes mellitus. Diabetes 31: 1016-1022
11. Kashiwagi A, Verso MA, Andrews J, Vasquez B, Reaven G, Foley JE (1983) In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus. J Clin Invest 72: 1246-1254
12. Scarlett JA, Kolterman OG, Ciaraldi TP, Kao M, Olefsky JM (1983) Insulin treatment reverses the postreceptor defect in adipocyte 3-O-methylglucose transport in type II diabetes mellitus. J Clin Endocrinol Metab 56: 1195-1201
13. Clarke JF, Young PW, Yonezawa K, Kasuga M, Holman GD (1994) Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin. Biochemical Journal 300: 631-635
14. Sanchez-Margalet V, Goldfine ID, Vlahos CJ, Sung CK (1994) Role of phosphatidylinositol-3-kinase in insulin receptor signaling: studies with inhibitor, LY294002. Biochem Biophys Res Commun 204: 446-452
15. Quon MJ, Chen H, Ing BL et al. (1995) Roles of 1-phosphatidylinositol 3-kinase and ras in regulating translocation of GLUT4 in transfected rat adipose cells. Mol Cel Biol 15: 5403-5411
16. Kotani K, Carozzi AJ, Sakaue H et al. (1995) Requirement for phosphoinositide 3-kinase in insulin-stimulated GLUT4 translocation in 3T3-L1 adipocytes. Biochem Biophys Res Commun 209: 343-348
17. Katagiri H, Asano T, Ishihara H et al. (1996) Overexpression of catalytic subunit p110alpha of phosphatidylinositol 3-kinase increases glucose transport activity with translocation of glucose transporters in 3T3-L1 adipocytes. J Biol Chem 271: 16987-16990
18. Martin SS, Haruta T, Morris AJ, Klippel A, Williams LT, Olefsky JM (1996) Activated phosphatidylinositol 3-kinase is sufficient to mediate actin rearrangement and GLUT4 translocation in 3T3-L1 adipocytes. J Biol Chem 271: 17605-17608
19. Saad MJ, Araki E, Miralpeix M, Rothenberg PL, White MF, Kahn CR (1992) Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance. J Clin Invest 90: 1839-1849
20. Saad MJ, Folli F, Kahn CR (1995) Insulin and dexamethasone regulate insulin receptors, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in Fao hepatoma cells. Endocrinology 136: 1579-1588
21. Sherman WM, Katz AL, Cutler CL, Withers RT, Ivy JL (1988) Glucose transport: locus of muscle insulin resistance in obese Zucker rats. Am J Physiol 255: E374-382
22. King PA, Horton ED, Hirshman MF, Horton ES (1992) Insulin resistance in obese Zucker rat (fa/fa) skeletal muscle is associated with a failure of glucose transporter translocation. J Clin Invest 90: 1568-1575
23. Uphues I, Kolter T, Goud B, Eckel J (1995) Failure of insulin-regulated recruitment of the glucose transporter GLUT4 in cardiac muscle of obese Zucker rats is associated with alterations of small-molecular-mass GTP-binding proteins. Biochem J 311: 161-166
24. Honnor RC, Dhillon GS, Londos C (1985) cAmp-dependent protein kinase and lipolysis in rat adipocytes. I. Cell preparation, manipulation, and predictability in behavior. J Biol Chem 260: 15 122-15 129
25. McKeel DW, Jarett L (1970) Preparation and characterization of a plasma membrane fraction from isolated fat cells. J Cell Biol 44: 417-432
26. Oppenheimer CL, Pessin JE, Massague J, Gitomer W, Czech MP (1983) Insulin action rapidly modulates the apparent affinity of the insulin-like growth factor II receptor. J Biol Chem 258: 4824-4830
27. Oka Y, Asano T, Shibasaki Y, Kasuga M, Kanazawa Y, Takaku F (1988) Studies with antipeptide antibody suggest the presence of at least two types of glucose transporter in rat brain and adipocyte. J Biol Chem 263: 13432-13439
28. Inukai K, Funaki M, Ogihara T et al. (1997) p85 gene generates three isoforms of regulatory subunit for phosphatidylinositol 3-kinase (PI 3-kinase), p50, p55 and p85, with different PI 3-kinase activity elevating responses to insulin. J Biol Chem 272: 7873-7882
29. Olefsky JM (1975) Effect of dexamethasone on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes. J Clin Invest 56: 1499-1508
30. Barrett-Connor E (1989) Epidemiology, obesity, and noninsulin-dependent diabetes mellitus. Epidemiol Rev 11: 172-181
31. Edelstein SL, Knowler WC, Bain RP et al. (1997) Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 46: 701-710
32. Grundleger ML, Thenen SW (1982) Decreased insulin binding, glucose transport, and glucose metabolism in soleus muscle of rats fed a high fat diet. Diabetes 31: 232-237
33. Susini C, Lavau M (1978) In-vitro and in-vivo responsiveness of muscle and adipose tissue to insulin in rats rendered obese by a high-fat diet. Diabetes 27: 114-120
34. Storlien LH, James DE, Burleigh KM, Chisholm DJ, Kraegen EW (1986) Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. Am J Physiol 251: E576-E583
35. Fujimoto WY, Bergstrom RW, Boyko EJ et al. (1994) Diabetes and diabetes risk factors in second- and third-generation Japanese Americans in Seattle. Washington. Diabetes Res Clin Pract 24 (Suppl): S43-52
36. Cederholm J, Wibell L (1985) Glucose tolerance and physical activity in a health survey of middle-aged subjects. Acta Med Scand 217: 373-378
37. Frisch RE, Wyshak G, Albright TE, Albright NL, Schiff I (1986) Lower prevalence of diabetes in female former college athletes compared with nonathletes. Diabetes 35: 1101-1105
38. Seals DR, Hagberg JM, Allen WK et al. (1984) Glucose tolerance in young and older athletes and sedentary men. J Appl Physiol 56: 1521-1525
39. Nagy K, Levy J, Grunberger G (1990) High-fat feeding induces tissue-specific alteration in proportion of activated insulin receptors in rats. Acta Endocrinol (Copenh) 122: 361-368
40. Stevenson RW, McPherson PK, Persson LM et al. (1996) The antihyperglycemic agent englitazone prevents the defect in glucose transport in rats fed a high-fat diet. Diabetes 45: 60-66
41. Kim YB, Nakajima R, Matsuo T et al. (1996) Gene expression of insulin signal-transduction pathway intermediates is lower in rats fed a beef tallow diet than in rats feel a safflower oil diet. Metabolism 45: 1080-1088
42. Pedersen O, Kahn CR, Flier JS, Kahn BB (1991) High fat feeding causes insulin resistance and a marked decrease in the expression of glucose transporters (Glut 4) in fat cells of rats. Endocrinology 129: 771-777
43. Asano T, Takata K, Katagiri H et al. (1992) Domains responsible for the differential targeting of glucose transporter isoforms. J Biol Chem 267: 19636-19641
44. Kahn BB (1996) Lilly lecture 1995. Glucose transport: pivotal step in insulin action. Diabetes 45: 1644-1654
45. Marette A, Burdett E, Douen A, Vranic M, Klip A (1992) Insulin induces the translocation of GLUT4 from a unique intracellular organelle to transverse tubules in rat skeletal muscle. Diabetes 41: 1562-1569
46. Koranyi LI, Bourey RE, Vuorinen-Markkola H et al. (1991) Level of skeletal muscle glucose transporter protein correlates with insulin-stimulated whole body glucose disposal in man. Diabetologia 34: 763-765
47. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 270: 12953-12956
48. Forman BM, Tontonoz, P, Chen J, Burn RP, Spiegelman BM, Evans RM (1995) 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83: 803-812
49. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83: 813-819
50. Lambe KG, Tugwood JD (1996) A human peroxisomeproliferator-activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs. Eur J Biochem 239: 1-7
51. Zhang B, Szalkowski D, Diaz E, Hayes N, Smith R, Berger J (1994) Potentiation of insulin stimulation of phosphatidylinositol 3-kinase by thiazolidinedione-derived antidiabetic agents in Chinese hamster ovary cells expressing human insulin receptors and L6 myotubes. J Biol Chem 269: 25735-25741
52. Maegawa H, Tachikawa-Ide R, Ugi S et al. (1993) Pioglitazone ameliorates high glucose induced desensitization of insulin receptor kinase in rat 1 fibroblasts in culture. Biochem Biophys Res Commun 197: 1078-1082
53. Kellerer M, kroder G, Tippmer S et al. (1994) Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts. Diabetes 43: 447-453
54. Kobayashi M, Iwanishi M, Egawa K, Shigeta Y (1992) Pioglitazone increases insulin sensitivity by activating insulin receptor kinase. Diabetes 41: 476-483
55. Turnbow MA, Smith LK, Garner CW (1995) The oxazolidinedione CP-92, 768-2 partially protects insulin receptor substrate-1 from dexamethasone down-regulation in 3T3-L1 adipocytes. Endocrinology 136: 1450-1458
56. Weinstein SP, Holand A, E OB, Haber RS (1993) Effects of thiazolidinediones on glucocorticoid-induced insulin resistance and GLUT4 glucose transporter expression in rat skeletal muscle. Metabolism 42: 1365-1369
57. Ciaraldi TP, Huber-Knudsen K, Hickman M, Olefsky JM (1995) Regulation of glucose transport in cultured muscle cells by novel hypoglycemic agents. Metabolism 44: 976-981
58. Hofmann C, Lorenz K, Colca JR (1991) Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone. Endocrinology 129: 1915-1925
59. Sandouk T, Reda D, Hofmann C (1993) The antidiabetic agent pioglitazone increases expression of glucose transporters in 3T3-F442A cells by increasing messenger ribonucleic acid transcript stability. Endocrinology 133: 352-359
60. Hirshman MF, Fagnant PM, Horton ED, King PA, Horton ES (1995) Pioglitazone treatment for 7 days failed to correct the defect in glucose transport and glucose transporter translocation in obese Zucker rat (fa/fa) skeletal muscle plasma membranes. Biochem Biophys Res Commun 208: 835-845
61. Young PW, Cawthorne MA, Coyle PJ et al. (1995) Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling. Diabetes 44: 1087-1092
62. Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I, Horikoshi H (1988) Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats. Diabetes 37: 1549-1558
63. Kaumi T, Hirano T, Odaka H et al. (1996) VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone. Diabetes 45: 806-811
64. Oakes ND, Kennedy CJ, Jenkins AB, Laybutt DR, Chisholm DJ, Kraegen EW (1994) A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat. Diabetes 43: 1203-1210
65. Inoue I, Takahashi K, Katayama S et al. (1995) Effect of troglitazone (CS-045) and bezafibrate on glucose tolerance, liver glycogen synthase activity, and beta-oxidation in fructose-fed rats. Metabolism 44: 1626-1630